OCGN - Spark Newswire

3 minute read

A Peek Into The Markets: US Stock Futures Edge Higher Following Thursday’s Rally

Today, 5:16 PM

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the S&P 500 settled at an all-time high in the previous session. Markets were closed on Friday in observance of the Christmas Day holiday.

ARES

1 minute read

5 Stocks To Watch For December 27, 2021

By Lisa Levin

Today, 5:16 PM

Some of the stocks that may grab investor focus today are:

AEZS

1 minute read

FDA
News

Drugs Controller General Of India Has Given Bharat Biotech Covaxin Emergency Use Approval For 12-18 Year Olds

By Charles Gross

Today, 5:16 PM

https://economictimes.indiatimes.com/news/india/bharat-biotechs-covid-19-vaccine-for-kids-gets-dcgi-nod-for-emergency-use/videoshow/88495174.cms

OCGN

2 minute read

Ocugen Shares Move Higher, Try To Recover A Key Technical Level

By Tyler Bundy

Today, 5:16 PM

Ocugen Inc. (NASDAQ: OCGN) shares are trading higher Tuesday as the stock attempts to recover a key support level. The stock looks to have no company specific news to explain the jump in price, but was trending higher on social media sites throughout the day. Ocugen closed up 5.61% at $5.46.

OCGN

3 minute read

25 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 5:16 PM

Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.

ABUS

1 minute read

Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination

By Vandana Singh

Today, 5:16 PM

Ocugen Inc (NASDAQ: OCGN) announced that

OCGN

3 minute read

Ocugen Highlights Data Analyzing Immune Response From Two Doses Of COVAXIN; Says Study Found COVAXIN ‘generated a robust immune memory against spike and nucleoprotein that was comparable to that following natural COVID-19 Infection…’

By Bill Haddad

Today, 5:16 PM

Level of vaccine-induced spike and nucleoprotein antibodies titers demonstrated to be comparable to that following natural infection Immune memory against conserved nucleoprotein may provide an added advantage over

OCGN

2 minute read

What’s Going On With Ocugen Stock Today

By Tyler Bundy

Today, 5:16 PM

Ocugen Inc. (NASDAQ: OCGN) shares are trading lower Tuesday as the stock breaks below a key support level. The stock has been in a steady decline throughout the past months falling from monthly highs of around $18.

OCGN

1 minute read

How Are The Shorts Feeling About Ocugen Inc?

By Benzinga Insights

Today, 5:16 PM

What happened: Ocugen Inc's (NASDAQ:OCGN) short interest has fallen 14% since the last report. The company recently reported that it has 46 million shares sold short, which is 24.05% of all regular shares that are available for trading.

OCGN

1 minute read

FDA
News

Ocugen, Inc. Announces U.S. FDA Acceptance Of Investigational New Drug Application To Initiate A Phase 1/2 Clinical Trial For Gene Therapy Candidate OCU400 To Treat Inherited Retinal Degeneration

By Benzinga Newsdesk

Today, 5:16 PM

Gene therapy candidate has potential to address a large number of retinitis pigmentosa and Leber congenital amaurosis gene mutations with a single product Trial to start in Q1 2022 will enroll

OCGN

Feed Symbols: OCGN